FFM
ONC

Fullerton Fund Management’s BeOne Medicines Ltd ONC Stock Holding History

Fullerton Fund Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,950
Closed -$744K – 94
2020
Q2 		$744K Sell
3,950
-85
-2% -$13.8K 0.14% 42
2020
Q1 		$497K Sell
4,035
-2,625
-39% -$411K 0.09% 30
2019
Q4 		$1.1M Sell
6,660
-289
-4% -$48K 0.23% 35
2019
Q3 		$851K Buy
6,949
+1,001
+17% +$133K 0.26% 28
2019
Q2 		$737K Sell
5,948
-159
-3% -$20.2K 0.25% 22
2019
Q1 		$806K Buy
6,107
+14
+0.2% +$1.89K 0.28% 19
2018
Q4 		$855K Buy
+6,093
New +$808K 0.49% 15

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Fullerton Fund Management's ONC Position: Q3 2020 in Review

Fullerton Fund Management sold out of BeOne Medicines Ltd (ONC) in Q3 2020, closing a stake of 3,950 shares — an estimated $744K sold.

Fullerton Fund Management first reported a position in ONC in Q4 2018 and held it in 7 quarters. The position peaked at $1.1M in Q4 2019. 244 funds tracked by Wall St. Rank hold ONC as of Q3 2020.

  • Fullerton Fund Management reported no remaining BeOne Medicines Ltd position as of Q3 2020 after selling out during the quarter.
  • Fullerton Fund Management sold 3,950 BeOne Medicines Ltd shares in Q3 2020, an estimated $744K.
  • Fullerton Fund Management first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 7 quarters.
  • Fullerton Fund Management's BeOne Medicines Ltd position peaked at $1.1M in Q4 2019.
  • 244 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2020.

Based on Fullerton Fund Management's 13F filing for Q3 2020, filed 16 Nov 2020.